论文信息 - Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial - 字舞流文

Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

W. Xu | Z. Cai | Jing Liu | Hong-guo Zhao | Wei Li | Z. Ge | Z. Shao | Hui Zhou | Wei Liu | R. Feng | P. Liu | Jun Zhu | Jianfeng Zhou | Junxun Ma | A. Liang | Xin Du | Jifeng Feng | L. Qiu | Mingzhi Zhang | F. Lv | Yan Li | Xiaohong Zhang | R. Xia | Y. Shuang | Qingyuan Zhang | M. Hou | Lin Liu | Wei Zhang | Hua-qing Wang | Ye Guo | S. Zeng | X. Zuo | Shune Yang | Zhendong Chen | W. Sang | Hui Zhou | D. Gao | Peng Liu | Lin Wang | Jie Yu | L. Zou | Haiwen Huang | Jinying Lin | M. Zheng | Yuqin Song | Wei Yang | W. Ran | Hongyu Zhang | Hao Xu | Hongxia Yao | Shuye Wang | K. Zhou | Huilai Zhang | Xinglan Sun | Qingfeng Zou | Y. Xiang | Ying-Ming Pang | Yongqing Cao | Mingzhi Zhang